Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: A cross-sectional study of nationally representative, individual-level data

Authors

Maja E Marcus, University of Goettingen
Mark D Huffman, Washington University School of Medicine in St. Louis
et al

Journal

Lancet Global Health

Publication Date

3-1-2022

Volume

10

Issue

3

First Page

e369

Last Page

e379

Document Type

Open Access Publication

DOI

10.1016/S2214-109X(21)00551-9

Rights and Permissions

Marcus ME, Manne-Goehler J, Theilmann M, Farzadfar F, Moghaddam SS, Keykhaei M, Hajebi A, Tschida S, Lemp JM, Aryal KK, Dunn M, Houehanou C, Bahendeka S, Rohloff P, Atun R, Bärnighausen TW, Geldsetzer P, Ramirez-Zea M, Chopra V, Heisler M, Davies JI, Huffman MD, Vollmer S, Flood D. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data. Lancet Glob Health. 2022 Mar;10(3):e369-e379. doi.org/10.1016/S2214-109X(21)00551-9. © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.

Recommended Citation

Marcus, Maja E; Huffman, Mark D; and et al, "Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: A cross-sectional study of nationally representative, individual-level data." Lancet Global Health. 10, 3. e369 - e379. (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11640